Skip to main content
. 2025 Aug 21;26(16):8109. doi: 10.3390/ijms26168109
SCC Squamous cell carcinoma
BCC Basal cell carcinoma
cSCC Cutaneous squamous cell carcinoma
CPR Complete pathological response
MPR Major pathological response
PPR Partial pathological response
NR No pathological response
ORR Objective response rate
TRAEs Treatment-related adverse effects
DSS Disease-specific survival
DFS Disease-free survival
EFS Event-free survival
QoL Quality of life
ICIs Immune checkpoint inhibitors
SOT Solid organ transplants
NAIT Neoadjuvant immunotherapy treatment